NEU neuren pharmaceuticals limited

Ann: DAYBUE (trofinetide) 2024 net sales US$348 million, page-34

  1. 2,099 Posts.
    lightbulb Created with Sketch. 549
    This is why Acadia will likely have a dip at taking over NEU, imagine another company owning the rights to all other indications for 2591 and Acadia has only a small part of the pie that they assisted in with NEU’s development; I truly doubt that Acadia will end up the eventual owner of NEU but it’ll start the bidding war IMHO, NEU is so sweetly placed for everything to develop in front of us it’s unbelievable, more patience is the key here.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.97
Change
-0.135(1.03%)
Mkt cap ! $1.613B
Open High Low Value Volume
$13.20 $13.36 $12.92 $2.273M 172.8K

Buyers (Bids)

No. Vol. Price($)
8 407 $12.96
 

Sellers (Offers)

Price($) Vol. No.
$12.97 189 12
View Market Depth
Last trade - 12.39pm 16/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.